Cullen Frost Bankers Inc. Cuts Stock Holdings in Fidelity National Financial, Inc. (NYSE:FNF)

Cullen Frost Bankers Inc. reduced its position in Fidelity National Financial, Inc. (NYSE:FNF) by 6.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 15,535 shares of the financial services provider’s stock after selling 1,022 shares during the quarter. Cullen Frost Bankers Inc.’s holdings in Fidelity National Financial were worth $793,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. VisionPoint Advisory Group LLC lifted its stake in shares of Fidelity National Financial by 107.0% in the third quarter. VisionPoint Advisory Group LLC now owns 737 shares of the financial services provider’s stock worth $30,000 after buying an additional 381 shares in the last quarter. Authentikos Wealth Advisory LLC purchased a new position in Fidelity National Financial in the 3rd quarter worth approximately $41,000. Orion Capital Management LLC acquired a new position in shares of Fidelity National Financial during the 3rd quarter worth approximately $51,000. SRS Capital Advisors Inc. grew its position in shares of Fidelity National Financial by 57.9% in the third quarter. SRS Capital Advisors Inc. now owns 1,415 shares of the financial services provider’s stock valued at $58,000 after purchasing an additional 519 shares in the last quarter. Finally, Neo Ivy Capital Management acquired a new stake in shares of Fidelity National Financial in the third quarter valued at approximately $63,000. Hedge funds and other institutional investors own 81.17% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the stock. Truist Financial raised their price objective on shares of Fidelity National Financial from $55.00 to $60.00 and gave the stock a “buy” rating in a research report on Friday, February 23rd. Keefe, Bruyette & Woods lifted their price target on shares of Fidelity National Financial from $54.00 to $56.00 and gave the company a “market perform” rating in a research report on Thursday, March 21st. Finally, Barclays increased their price objective on Fidelity National Financial from $52.00 to $56.00 and gave the stock an “equal weight” rating in a research report on Tuesday, April 9th. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $54.20.

Insider Activity at Fidelity National Financial

In other Fidelity National Financial news, Director Cary H. Thompson sold 23,410 shares of the business’s stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $51.11, for a total transaction of $1,196,485.10. Following the completion of the transaction, the director now owns 40,317 shares in the company, valued at approximately $2,060,601.87. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In related news, Director Cary H. Thompson sold 23,410 shares of the business’s stock in a transaction on Monday, March 4th. The shares were sold at an average price of $51.11, for a total transaction of $1,196,485.10. Following the completion of the transaction, the director now owns 40,317 shares in the company, valued at $2,060,601.87. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Halim Dhanidina sold 3,000 shares of Fidelity National Financial stock in a transaction dated Friday, April 26th. The stock was sold at an average price of $50.64, for a total value of $151,920.00. Following the sale, the director now directly owns 14,906 shares of the company’s stock, valued at $754,839.84. The disclosure for this sale can be found here. 5.40% of the stock is owned by corporate insiders.

Fidelity National Financial Stock Up 0.9 %

NYSE:FNF opened at $52.60 on Friday. Fidelity National Financial, Inc. has a 52 week low of $33.61 and a 52 week high of $53.96. The company has a quick ratio of 0.21, a current ratio of 0.21 and a debt-to-equity ratio of 0.52. The stock’s fifty day moving average is $50.75 and its two-hundred day moving average is $48.56. The stock has a market capitalization of $14.37 billion, a price-to-earnings ratio of 27.54 and a beta of 1.33.

Fidelity National Financial (NYSE:FNF) last announced its earnings results on Wednesday, May 8th. The financial services provider reported $0.76 EPS for the quarter, missing analysts’ consensus estimates of $0.84 by ($0.08). The firm had revenue of $3.30 billion for the quarter, compared to analysts’ expectations of $2.72 billion. Fidelity National Financial had a net margin of 4.40% and a return on equity of 13.91%. The business’s revenue was up 33.3% compared to the same quarter last year. During the same quarter last year, the business earned $0.52 earnings per share. Research analysts anticipate that Fidelity National Financial, Inc. will post 4.83 EPS for the current year.

Fidelity National Financial Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 28th. Stockholders of record on Friday, June 14th will be paid a $0.48 dividend. This represents a $1.92 annualized dividend and a dividend yield of 3.65%. The ex-dividend date is Friday, June 14th. Fidelity National Financial’s payout ratio is presently 100.52%.

Fidelity National Financial Profile

Fidelity National Financial, Inc, together with its subsidiaries, provides various insurance products in the United States. The company operates through Title, F&G, and Corporate and Other segments. It offers title insurance, escrow, and other title related services, including trust activities, trustee sales guarantees, recordings and reconveyances, and home warranty products.